Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: May 28, 2009


Thermo Fisher Scientific named two new directors to its board this week, Thomas Lynch, and Tyler Jacks.

Lynch is the CEO of Tyco Electronics. He previously held management positions at Motorola and General Instrument. In April 2008, he was appointed to President Bush's National Security Telecommunications Advisory Committee.

Jacks is the David H. Koch professor of biology at the Massachusetts Institute of Technology where he is also the director of the David H. Koch Institute for Integrative Cancer Research. He was director of the MIT Center for Cancer Research from 2001 to 2008.

Strategic Diagnostics announced this week Kevin Bratton has joined the company as vice president of finance and Chief Financial Officer, effective June 1.

Bratton joins SDI from EUSA Pharma where he was senior vice president of business operations. Before that he was senior vice president and CFO of Cytogen before it was acquired by EUSA.

Caris Diagnostics announced this week the appointment of David Loesch as director of oncology, clinical trials, and services.

Loesch has been a practicing medical oncologist for more than 18 years and served as co-chairman of the Breast Cancer Committee of the US Oncology Network.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.